company background image
SHL

Siemens HealthineersXTRA:SHL Stock Report

Market Cap

€72.3b

7D

-0.4%

1Y

68.2%

Updated

29 Nov, 2021

Data

Company Financials +
SHL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance3/6
Financial Health4/6
Dividends3/6

SHL Stock Overview

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide.

Siemens Healthineers Competitors

Roche Holding

SWX:ROG

CHF309.5b

Thermo Fisher Scientific

NYSE:TMO

US$251.7b

Danaher

NYSE:DHR

US$233.3b

Abbott Laboratories

NYSE:ABT

US$226.4b

Price History & Performance

Summary of all time highs, changes and price drops for Siemens Healthineers
Historical stock prices
Current Share Price€64.46
52 Week High€67.50
52 Week Low€38.04
Beta0.45
1 Month Change12.18%
3 Month Change8.05%
1 Year Change68.19%
3 Year Change67.13%
5 Year Changen/a
Change since IPO113.44%

Recent News & Updates

Sep 06
Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet

Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

SHLDE Medical EquipmentDE Market
7D-0.4%-0.3%-4.3%
1Y68.2%58.6%16.0%

Return vs Industry: SHL exceeded the German Medical Equipment industry which returned 58.6% over the past year.

Return vs Market: SHL exceeded the German Market which returned 16% over the past year.

Price Volatility

Is SHL's price volatile compared to industry and market?
SHL volatility
SHL Average Weekly Movement3.8%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in DE Market9.0%
10% least volatile stocks in DE Market2.5%

Stable Share Price: SHL is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: SHL's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a66,000Bernd Montaghttps://www.siemens-healthineers.com

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.

Siemens Healthineers Fundamentals Summary

How do Siemens Healthineers's earnings and revenue compare to its market cap?
SHL fundamental statistics
Market Cap€72.31b
Earnings (TTM)€1.73b
Revenue (TTM)€18.00b

41.9x

P/E Ratio

4.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SHL income statement (TTM)
Revenue€18.00b
Cost of Revenue€11.05b
Gross Profit€6.95b
Expenses€5.23b
Earnings€1.73b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

Feb 03, 2022

Earnings per share (EPS)1.54
Gross Margin38.63%
Net Profit Margin9.60%
Debt/Equity Ratio83.6%

How did SHL perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

51%

Payout Ratio

Does SHL pay a reliable dividends?

See SHL dividend history and benchmarks
When do you need to buy SHL by to receive an upcoming dividend?
Siemens Healthineers dividend dates
Ex Dividend DateFeb 14 2022
Dividend Pay DateFeb 16 2022
Days until Ex dividend75 days
Days until Dividend pay date77 days

Does SHL pay a reliable dividends?

See SHL dividend history and benchmarks

Valuation

Is Siemens Healthineers undervalued compared to its fair value and its price relative to the market?

25.6%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: SHL (€64.46) is trading below our estimate of fair value (€86.68)

Significantly Below Fair Value: SHL is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: SHL is poor value based on its PE Ratio (41.9x) compared to the German Medical Equipment industry average (28.8x).

PE vs Market: SHL is poor value based on its PE Ratio (41.9x) compared to the German market (20.7x).


Price to Earnings Growth Ratio

PEG Ratio: SHL is poor value based on its PEG Ratio (3x)


Price to Book Ratio

PB vs Industry: SHL's PB Ratio (4.4x) is in line with the DE Medical Equipment industry average.


Future Growth

How is Siemens Healthineers forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?

14.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SHL's forecast earnings growth (14.2% per year) is above the savings rate (-0.01%).

Earnings vs Market: SHL's earnings (14.2% per year) are forecast to grow faster than the German market (12.2% per year).

High Growth Earnings: SHL's earnings are forecast to grow, but not significantly.

Revenue vs Market: SHL's revenue (7% per year) is forecast to grow faster than the German market (6% per year).

High Growth Revenue: SHL's revenue (7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SHL's Return on Equity is forecast to be low in 3 years time (15.9%).


Past Performance

How has Siemens Healthineers performed over the past 5 years?

5.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SHL has high quality earnings.

Growing Profit Margin: SHL's current net profit margins (9.6%) are lower than last year (9.8%).


Past Earnings Growth Analysis

Earnings Trend: SHL's earnings have grown by 5.7% per year over the past 5 years.

Accelerating Growth: SHL's earnings growth over the past year (22.4%) exceeds its 5-year average (5.7% per year).

Earnings vs Industry: SHL earnings growth over the past year (22.4%) underperformed the Medical Equipment industry 76.9%.


Return on Equity

High ROE: SHL's Return on Equity (10.7%) is considered low.


Financial Health

How is Siemens Healthineers's financial position?


Financial Position Analysis

Short Term Liabilities: SHL's short term assets (€10.8B) exceed its short term liabilities (€10.1B).

Long Term Liabilities: SHL's short term assets (€10.8B) do not cover its long term liabilities (€15.8B).


Debt to Equity History and Analysis

Debt Level: SHL's net debt to equity ratio (75%) is considered high.

Reducing Debt: SHL's debt to equity ratio has reduced from 398.3% to 83.6% over the past 5 years.

Debt Coverage: SHL's debt is well covered by operating cash flow (21.5%).

Interest Coverage: SHL's interest payments on its debt are well covered by EBIT (51.1x coverage).


Balance Sheet


Dividend

What is Siemens Healthineers's current dividend yield, its reliability and sustainability?

1.32%

Current Dividend Yield


Upcoming Dividend Payment

TodayNov 30 2021Ex Dividend DateFeb 14 2022Dividend Pay DateFeb 16 20222 days from Ex DividendBuy in the next 75 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: SHL's dividend (1.32%) is higher than the bottom 25% of dividend payers in the German market (1.01%).

High Dividend: SHL's dividend (1.32%) is low compared to the top 25% of dividend payers in the German market (3.42%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, SHL has been paying a dividend for less than 10 years.

Growing Dividend: SHL's dividend payments have increased, but the company has only paid a dividend for 3 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (50.9%), SHL's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: SHL's dividends in 3 years are forecast to be well covered by earnings (46.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

Bernd Montag (52 yo)

6.83yrs

Tenure

€3,763,000

Compensation

Dr. Bernhard Montag, also known as Bernd, serves as President and at Chairman of Management Board Siemens at Healthineers AG and has been its Chief Executive Officer and Member of Management Board since 20...


CEO Compensation Analysis

Compensation vs Market: Bernd's total compensation ($USD4.24M) is about average for companies of similar size in the German market ($USD4.56M).

Compensation vs Earnings: Bernd's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: SHL's management team is considered experienced (3 years average tenure).


Board Members

Experienced Board: SHL's board of directors are considered experienced (3.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.8%.


Top Shareholders

Company Information

Siemens Healthineers AG's employee growth, exchange listings and data sources


Key Information

  • Name: Siemens Healthineers AG
  • Ticker: SHL
  • Exchange: XTRA
  • Founded: NaN
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €72.310b
  • Shares outstanding: 1.12b
  • Website: https://www.siemens-healthineers.com

Number of Employees


Location

  • Siemens Healthineers AG
  • Henkestrasse 127
  • Erlangen
  • Bavaria
  • 91052
  • Germany

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/29 23:11
End of Day Share Price2021/11/29 00:00
Earnings2021/09/30
Annual Earnings2021/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.